"I cannot tell you how much I enjoy working with everyone at the Centre. It is great to feel part of your team"
Decision-making for localized disease
External beam radiotherapy
High dose rate (HDR) brachytherapy
Localised prostate cancer
Locally advanced prostate cancer
Metastatic prostate cancer
Heather specialises in the management of urological malignancies and is actively involved in clinical research. As well as her research into hormones and radiotherapy she has pioneered a programme of high-dose rate (HDR) brachytherapy which is a minimally invasive treatment for prostate cancer. Currently chairman of the British Uro-oncology Group (BUG), Heather serves on the Prostate Cancer Charter for Action and the Department of Health Prostate Cancer Advisory Group; she is a Trustee of Prostate UK and of the Prostate Cancer Research Centre. She enjoys and has particular expertise in helping patients with quality of life and decision-making issues with regard to their treatment options.